Nystatin for human use
- polyene macrolide antibiotic obtained from the fermentation of the strain Streptomyces noursei
- effective against moulds and yeast, mainly against Candida Albicans. Candida causes fungal infections of the skin, mouth, vagina and the gastrointestinal tract
- has shown no problems of drugs interactions and side allergic or resistance effects since 1950 when discovered
Standardní výroba
Parametry | Limity |
---|---|
Loss on drying | not more than 5 % |
Microbiological assay | not less than 4400 IU/mg (dried substance) or not less than 5000 IU/mg (dried substance) for oral use |
Particle size | The particle size distribution range of nystatin is typically: 100 % of particles is less than 40 μm 90 % of particles is less than 10 μm |
Pharmacopoeial Quality
USP, Ph. Eur., BP
Regulatory information/Certifi cation
GMP, Certifi cate of Suitability R1-CEP 2003-118-Rev 01, US DMF # 14056, EIR from FDA, U.S.A., national registrations in many countries all over the world
Packaging and Shipping
Standard: polyethylene bag in PET/Al/PE bag in fi ber drums (50 or 100 BOU).
Non-standard: according to requirements
Shelf-life
3 years in the original packaging
Storage conditions
Store below 25ÅãC, in tight, light persistent container